亚洲精品国产你懂的在线观看_a级毛片无码免费久久_欧美在线成人91_欧美性色欧美a在线图片_午夜精品福利视频网址_国产精品爆乳在线播放在线看_婷婷六月综合激情_中文字幕一区二区三区导航_吉泽明步无码torrent_强被迫伦姧惨叫人妻系列

CIRS
Hot Search
Registration & Filing
HotLine:+86 571 88393962
China Cosmetic Registration and Filing
Under Cosmetics Supervision and Administration Regulations (CSAR) issued in 2020, cosmetics are divided into two types: special and ordinary.. Special cosmetics are products for the function of anti-freckle/whitening, sunscreen, hair dye, hair perm, anti-hair loss and new efficacies. Ordinary cosmetics are those other than special cosmetics. Companies who plan to place cosmetics on Chinese market must apply for the registration or filing with the NMPA or provincial MPA to get approval license or certificate. Toothpaste will be regulated as ordinary cosmetics. Companies who intend to sell cosmetics products via offline stores in China as well as companies who intend to sell cosmetics products via online platforms except cross-border e-commerce such as TMALL, JD, etc., shall complete the registration.
China New Cosmetic Ingredient Registration and Filing
Under Cosmetics Supervision and Administration Regulations (CSAR) issued in 2020, companies shall apply for the registration and filing of cosmetic ingredients not listed in Inventory of Existing Cosmetic Ingredients in China (IECIC 2021). New cosmetic ingredients refer to natural or artificial raw materials used in cosmetics for the first time in China. They can be divided into 2 types: New cosmetic ingredients with high safety risk(s), such as preservatives, colorants, anti-freckle/whitening agents, sunscreen agents and hair dyes and New cosmetic ingredients without high safety risk(s).
China Cosmetic Formula/Label/Claim Review
China Cosmetic Formulation, Label and Claim Review.

Disclaimer

CIRS KEXIN Biotech accepts no responsibility or liability whatsoever with regard to the information on this website. Reproduction for non-commercial purposes of information and documents from the our  website is authorised provided that you acknowledge "CIRS KEXIN Biotech" as the source.